[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-349724-105":59,"doc-detail-349724-en":135},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":128,"head_meta":130,"extra_data":132,"updated_unix":134},105,"en","clinical-and-prognostic-factors-of-submandibular-gland-malignancies-a-seer-based-analysis","Clinical and Prognostic Factors of Submandibular Gland Malignancies: A SEER-Based Analysis","","Objective: Examine clinical and prognostic determinants of submandibular gland malignancies, a rare cancer type with an estimated ~50% malignancy risk and limited existing clinical evidence. Methods: Conduct a retrospective SEER-based population analysis of primary submandibular gland malignancies from 2000–2019, using Kaplan–Meier survival curves, log-rank tests by grade, stage, histology, and treatment, and Royston–Parmar proportional odds models to estimate odds of death. Results: Analyze 2875 patients and identify survival differences by tumor grade, histologic subtype, and treatment. Conclusion: Multivariate results indicate lower odds of death with surgical-based treatments; radiation and chemoradiotherapy alone show no significant difference.",{"@graph":69,"@context":127},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/clinical-and-prognostic-factors-of-submandibular-gland-malignancies-a-seer-based-analysis/349724/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/clinical-and-prognostic-factors-of-submandibular-gland-malignancies-a-seer-based-analysis/349724.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",11,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119,123],{"name":110,"@type":111,"acceptedAnswer":112},"Why focus on clinical and prognostic factors for submandibular gland malignancies?","Question",{"text":113,"@type":114},"Submandibular gland tumors are rare and malignancy risk is high, but clinical and prognostic information is limited, motivating a SEER-based evaluation.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were survival differences assessed in the study?",{"text":118,"@type":114},"Kaplan–Meier curves and log-rank tests evaluated survival differences by tumor grade, histologic subtype, stage, and treatment patterns.",{"name":120,"@type":111,"acceptedAnswer":121},"What treatments were associated with improved outcomes?",{"text":122,"@type":114},"Treatments involving surgery—alone or with adjuvant radiation and/or chemoradiotherapy—were linked to significantly lower odds of death in the overall sample.",{"name":124,"@type":111,"acceptedAnswer":125},"Why were radiation or chemoradiotherapy alone not significantly different in multivariate results?",{"text":126,"@type":114},"The study suggests these patients were likely poor surgical candidates or had advanced metastatic disease, which may explain the lack of significant differences when considered alone.","https://schema.org",{"og:url":83,"og:type":129,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":131,"canonical":83},"index,follow",{"doc_id":133,"site_id":62},349724,1790511832,{"code":4,"msg":5,"data":136},{"doc_id":133,"user_id":137,"nickname":92,"user_avatar":138,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":139,"file_id":140,"file_url":141,"file_type":142,"file_size":143,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":144,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":67,"update_tm":148,"read_time":149,"preview_page_count":19,"preview_urls":150},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","Head and Neck Pathology (2026) 20:13  \n[https://doi.org/10.1007/s12105-025-01882-z](https://doi.org/10.1007/s12105-025-01882-z)  \nRESEARCH  \nClinical and Prognostic Factors of Submandibular Gland Malignancies: A SEER-Based Analysis  \nAnalysis of Submandibular Gland Tumors  \nPriya Arya1 · Logan W. Brown1 · Mikalah E. Maury1 · Kimberly B. Roth1 · David H. Posas1 · Robert M. Liebman2 ·  \nMatthew C. Ochsner2  \nReceived: 26 October 2025 / Accepted: 19 December 2025 © The Author(s) 2026  \nAbstract  \nObjective While neoplasms of the submandibular gland (SMG) are rare, there is a nearly 50% risk of malignancy and its neoplasms are associated with poorer prognoses. Due to the rarity of these tumors, clinical and prognostic information relating to these tumors is limited; we aimed to elucidate these factors using an analysis of the Surveillance, Epidemiology, and End Results (SEER) database.  \nMethods A retrospective population-based analysis was performed with data regarding primary SMG malignancy from 2000 to 2019 as extracted from the SEER database. Kaplan–Meier curves and log-rank tests assessed differences in survival by tumor grade and treatment. To estimate odds of death, Royston-Parmar Proportional Odds models were used. Stratified analyses were conducted by tumor stage and histology subtype.  \nResults Data from 2875 patients were extracted. Kaplan–Meier analyses on a sample of 2809 patients showed survival differing significantly by tumor grade, histologic subtype, and treatment (p\u003C 0.0001) . Most favorable survival outcomes were amongst mucoepidermoid neoplasms, ductal and lobular neoplasms, and adenocarcinomas, and least favorable survival outcomes amongst epithelial and squamous cell neoplasms. Surgery alone and with adjuvant radiation and chemoradiotherapy both showed significantly lower odds of death for the overall sample.  \nConclusion Multi-variate analysis indicated significantly lower odds of death with treatments involving surgery, while no significant differences were seen for radiation and chemoradiotherapy alone, likely due to the latter patients being poor surgical candidates or with advanced metastatic disease. Optimal treatment modalities for SMG malignancies are still being determined.  \nKeywords Submandibular gland malignancy · Head and neck tumors · Benign · Malignant · Epidemiology  \nIntroduction  \nSalivary gland malignancies encompass approximately 3–5% of head and neck cancers with 5–15% isolated from the submandibular gland (SMG) [1–4] . The preponderance of major salivary gland malignancies has steadily increased.  \n􀀍 Logan W. Brown [Logan.W.Brown@live.mercer.edu](Logan.W.Brown@live.mercer.edu)  \n1 Mercer University School of Medicine, 1250 E 66th St, Savannah, GA 31404, USA  \n2 Department of Otolaryngology, Memorial Hospital University Medical Center, Savannah, GA, USA  \nMost are found in the parotid and submandibular glands and fewer cases reported within sublingual and minor salivary glands [1] . Relative to the parotid, SMG neoplasms have a rate of malignancy nearly twice as high and are associated with poorer prognoses [2] .  \nNumerous exposures have been implicated in the development of salivary gland neoplasms, including modifiable factors such as alcohol and tobacco usage. Benign and malignant SMG neoplasms encompass a spectrum of histological types, and in most cases, surgical removal of the submandibular gland with possible adjuvant radiation therapy is the gold standard [3]. A neck dissection can be performed at the time of the initial surgery depending on the histology and stage. Other treatments in the literature include  \n1 3  \nradiotherapy, chemoradiotherapy, and chemotherapy. Various factors contribute to survival including extent of lymph node involvement, local tissue invasion, and distant metastasis. However, information about these tumors' clinical and prognostic factors remains limited due to their rarity.  \nIn recent years, few updates have been made synthesizing the epidemiology an","cbCailmL97aMYXLf","https://ap.wps.com/l/cbCailmL97aMYXLf","pdf",1297246,"English","# Abstract\n## Objective\n## Methods\n## Results\n## Conclusion\n# Introduction\n# Methods\n## Data Extraction\n## Participants and Variables","[{\"question\":\"Why focus on clinical and prognostic factors for submandibular gland malignancies?\",\"answer\":\"Submandibular gland tumors are rare and malignancy risk is high, but clinical and prognostic information is limited, motivating a SEER-based evaluation.\"},{\"question\":\"How were survival differences assessed in the study?\",\"answer\":\"Kaplan–Meier curves and log-rank tests evaluated survival differences by tumor grade, histologic subtype, stage, and treatment patterns.\"},{\"question\":\"What treatments were associated with improved outcomes?\",\"answer\":\"Treatments involving surgery—alone or with adjuvant radiation and/or chemoradiotherapy—were linked to significantly lower odds of death in the overall sample.\"},{\"question\":\"Why were radiation or chemoradiotherapy alone not significantly different in multivariate results?\",\"answer\":\"The study suggests these patients were likely poor surgical candidates or had advanced metastatic disease, which may explain the lack of significant differences when considered alone.\"}]","Clinical and Prognostic Factors of Submandibular Gland Malignancies: A SEER-Based Analysis | PDF",1790085222,25,[151,155,159,163],{"page_no":8,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed12d435f94769915796aeeb5a98c991.webp",983,1305,{"page_no":14,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89a9632a36211abd2af6b2625c3f46c1.webp",982,1304,{"page_no":81,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/88647498fd8ef8d443cf05dd9e9157cf.webp",981,1303,{"page_no":19,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8acd53f2f31fed3dbfb38f47938dc85d.webp",980,1301]